6 active not recruiting. 6 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Active not recruiting 6 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women GBS-NN/NN2 vaccine - Streptococcus Agalactiae Infection, Neonatal Sepsis | Phase 2 / Phase 3 | Active not recruiting | Minervax ApS | 137 | 2025-03-07 | 2026-09-04 |
| Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants Formulation B, Formulation C, Formulation D - Pneumococcal Disease, Invasive | Phase 2 | Active not recruiting | Inventprise Inc. | 421 | 2025-01-27 | 2025-09-02 |
| A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants 0.5 mL of the low dose VAX-31, 0.5 mL of the mid dose VAX-31, 0.5 mL of the high dose VAX-31 - Pneumococcal Vaccines | Phase 2 | Active not recruiting | Vaxcyte, Inc. | 900 | 2024-11-25 | 2026-05-15 |
| Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age. IVT GBS-06, Placebo - Group B Streptococcal Infections | Phase 1 / Phase 2 | Active not recruiting | Inventprise Inc. | 600 | 2024-11-12 | 2025-11-18 |
| A Study to Learn About How a New Pneumococcal Vaccine Works in Infants PG4, 20-valent pneumococcal conjugate vaccine (20vPnC), 15-valent pneumococcal conjugate vaccine (PCV15) - Pneumococcal Disease | Phase 2 | Active not recruiting | Pfizer | 605 | 2024-07-25 | 2026-10-19 |
| GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial phenoxymethyl penicillin, intramuscular benzathine penicillin G (BPG) prophylaxis - Rheumatic Heart Disease | Phase 2 | Active not recruiting | Children's Hospital Medical Center, Cincinnati | 1004 | 2023-09-01 | 2026-10-19 |
Pneumococcal Infections (3) · Pneumonia (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1) · Meningitis (1) · Neonatal Sepsis (1) · Rheumatic Heart Disease (1)
Bacterial Infections (5) · Bacterial Infections and Mycoses (5) · Gram-Positive Bacterial Infections (5) · Infections (5) · Lung Diseases (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Diseases (1) · Infant, Newborn, Diseases (1) · Inflammation (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1)
D-Worm (1) · Penicillin G (1) · Penicillin V (1)
Inventprise Inc. (2) · Children's Hospital Medical Center, Cincinnati (1) · Minervax ApS (1) · Pfizer (1) · Vaxcyte, Inc. (1)
United States (3) · Puerto Rico (2) · South Africa (2) · Denmark (1) · Philippines (1) · Uganda (1)
Andrea Z Beaton (1) · Sybil Tasker, MD, MPH, FIDSA (1)
2025 (1)